• 19966 Citations
  • 72 Scopus h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)

Parikh, K., Mandrekar, S. J., Allen-Ziegler, K., Esplin, B., Tan, A. D., Marchello, B., Adjei, A. A. & Molina, J. R., Jun 1 2020, In : Oncologist. 25, 6, p. 523-531 9 p.

Research output: Contribution to journalArticle

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

Zhu, M., Molina, J. R., Dy, G. K., Croghan, G. A., Qi, Y., Glockner, J., Hanson, L. J., Roos, M. M., Tan, A. D. & Adjei, A. A., 2020, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study

Schenk, E. L., Mandrekar, S. J., Dy, G. K., Aubry, M. C., Tan, A. D., Dakhil, S. R., Sachs, B. A., Nieva, J. J., Bertino, E., Lee Hann, C., Schild, S. E., Wadsworth, T. W., Adjei, A. A. & Molina, J. R., Jan 2020, In : Journal of Thoracic Oncology. 15, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)

the task force on Methodology for the Development of Innovative Cancer Therapies, Jun 1 2020, In : Clinical Cancer Research. 26, 11, p. 2461-2465 5 p.

Research output: Contribution to journalReview article

Development and Reporting of Prediction Models: Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

Leisman, D. E., Harhay, M. O., Lederer, D. J., Abramson, M., Adjei, A. A., Bakker, J., Ballas, Z. K., Barreiro, E., Bell, S. C., Bellomo, R., Bernstein, J. A., Branson, R. D., Brusasco, V., Chalmers, J. D., Chokroverty, S., Citerio, G., Collop, N. A., Cooke, C. R., Crapo, J. D., Donaldson, G. & 19 others, Fitzgerald, D. A., Grainger, E., Hale, L., Herth, F. J., Kochanek, P. M., Marks, G., Moorman, J. R., Ost, D. E., Schatz, M., Sheikh, A., Smyth, A. R., Stewart, I., Stewart, P. W., Swenson, E. R., Szymusiak, R., Teboul, J. L., Vincent, J. L., Wedzicha, J. A. & Maslove, D. M., 2020, (Accepted/In press) In : Critical care medicine. p. 623-633 11 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

Does the Lung Cancer Field Need Another Third-Generation EGFR Tyrosine Kinase Inhibitor?

Wang, F. & Adjei, A. A., Jun 2020, In : Journal of Thoracic Oncology. 15, 6, p. 881-883 3 p.

Research output: Contribution to journalEditorial

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Remon, J., Passiglia, F., Ahn, M. J., Barlesi, F., Forde, P. M., Garon, E. B., Gettinger, S., Goldberg, S. B., Herbst, R. S., Horn, L., Kubota, K., Lu, S., Mezquita, L., Paz-Ares, L., Popat, S., Schalper, K. A., Skoulidis, F., Reck, M., Adjei, A. A. & Scagliotti, G. V., 2020, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalReview article

6 Scopus citations

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer

Duma, N., Idossa, D. W., Durani, U., Frank, R. D., Paludo, J., Westin, G., Lou, Y., Mansfield, A. S., Adjei, A. A., Go, R. S. & Ailawadhi, S., May 2020, In : Clinical lung cancer. 21, 3, p. e115-e129

Research output: Contribution to journalArticle

Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma

Friedberg, J. S., Culligan, M. J., Tsao, A. S., Rusch, V., Adusumilli, P. S., Sepesi, B., Pass, H. I., Bueno, R., Burt, B., Sugarbaker, D. J., de Perrot, M., Adjei, A. A., Hirsch, F. R., Malik, S. M. & Harpole, D. J., May 2020, In : Journal of Thoracic Oncology. 15, 5, p. e75-e77

Research output: Contribution to journalLetter

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

Dingemans, A. M. C., Soo, R. A., Jazieh, A. R., Rice, S. J., Kim, Y. T., Teo, L. L. S., Warren, G. W., Xiao, S. Y., Smit, E. F., Aerts, J. G., Yoon, S. H., Veronesi, G., De Cobelli, F., Ramalingam, S. S., Garassino, M. C., Wynes, M. W., Behera, M., Haanen, J., Lu, S., Peters, S. & 4 others, Ahn, M. J., Scagliotti, G. V., Adjei, A. A. & Belani, C. P., Jul 2020, In : Journal of Thoracic Oncology. 15, 7, p. 1119-1136 18 p.

Research output: Contribution to journalReview article

Open Access
4 Scopus citations

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

Parikh, K., Huether, R., White, K., Hoskinson, D., Beaubier, N., Dong, H., Adjei, A. A. & Mansfield, A. S., Feb 5 2020, In : JAMA Network Open. 3, 2, p. e200202

Research output: Contribution to journalArticle

Open Access
2019

5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study

Luo, Y. H., Luo, L., Wampfler, J. A., Wang, Y., Liu, D., Chen, Y. M., Adjei, A., Midthun, D. E. & Yang, P., Aug 1 2019, In : The Lancet Oncology. 20, 8, p. 1098-1108 11 p.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies

Xie, H. & Adjei, A. A., Mar 2019, In : Journal of Thoracic Oncology. 14, 3, p. 358-376 19 p.

Research output: Contribution to journalReview article

2 Scopus citations

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib with Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

Ma, W. W., Xie, H., Fetterly, G., Pitzonka, L., Whitworth, A., Levea, C., Wilton, J., Mantione, K., Schihl, S., Dy, G. K., Boland, P., Iyer, R., Tan, W., Brady, W., Straubinger, R. M. & Adjei, A. A., Feb 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 2, p. 184-189 6 p.

Research output: Contribution to journalArticle

4 Scopus citations

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Xie, H., Yin, J., Shah, M. H., Menefee, M. G., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A. A., Aug 15 2019, In : Investigational New Drugs. 37, 4, p. 755-762 8 p.

Research output: Contribution to journalArticle

2 Scopus citations
1 Scopus citations

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce

Friedberg, J. S., Culligan, M. J., Tsao, A. S., Rusch, V., Sepesi, B., Pass, H. I., Bueno, R., Burt, B., Sugarbaker, D. J., de Perrot, M., Adjei, A. A., Adusumilli, P. S., Hirsch, F. R., Malik, S. M. & Harpole, D. J., Aug 2019, In : Journal of Thoracic Oncology. 14, 8, p. 1343-1353 11 p.

Research output: Contribution to journalReview article

6 Scopus citations

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Duma, N., Kothadia, S. M., Azam, T. U., Yadav, S., Paludo, J., Vera Aguilera, J., Gonzalez Velez, M., Halfdanarson, T. R., Molina, J. R., Hubbard, J. M., Go, R. S., Mansfield, A. S. & Adjei, A. A., Jan 2019, In : Oncologist. 24, 1, p. 96-102 7 p.

Research output: Contribution to journalReview article

3 Scopus citations

Control of confounding and reporting of results in causal inference studies

Lederer, D. J., Bell, S. C., Branson, R. D., Chalmers, J. D., Marshall, R., Maslove, D. M., Ost, D. E., Punjabi, N. M., Schatz, M., Smyth, A. R., Stewart, P. W., Suissa, S., Adjei, A. A., Akdis, C. A., Azoulay, É., Bakker, J., Ballas, Z. K., Bardin, P. G., Barreiro, E., Bellomo, R. & 28 others, Bernstein, J. A., Brusasco, V., Buchman, T. G., Chokroverty, S., Collop, N. A., Crapo, J. D., Fitzgerald, D. A., Hale, L., Hart, N., Herth, F. J., Iwashyna, T. J., Jenkins, G., Kolb, M., Marks, G. B., Mazzone, P., Moorman, J. R., Murphy, T. M., Noah, T. L., Reynolds, P., Riemann, D., Russell, R. E., Sheikh, A., Sotgiu, G., Swenson, E. R., Szczesniak, R., Szymusiak, R., Teboul, J. L. & Vincent, J. L., Jan 2019, In : Annals of the American Thoracic Society. 16, 1, p. 22-28 7 p.

Research output: Contribution to journalReview article

104 Scopus citations

Current Diagnosis and Management of Small-Cell Lung Cancer

Wang, S., Zimmermann, S., Parikh, K., Mansfield, A. S. & Adjei, A. A., Aug 2019, In : Mayo Clinic proceedings. 94, 8, p. 1599-1622 24 p.

Research output: Contribution to journalReview article

Open Access
8 Scopus citations

Gender medicine and oncology: Report and consensus of an ESMO workshop

Wagner, A. D., Oertelt-Prigione, S., Adjei, A., Buclin, T., Cristina, V., Csajka, C., Coukos, G., Dafni, U., Dotto, G. P., Ducreux, M., Fellay, J., Haanen, J., Hocquelet, A., Klinge, I., Lemmens, V., Letsch, A., Mauer, M., Moehler, M., Peters, S. & Özdemir, B. C., Dec 1 2019, In : Annals of Oncology. 30, 12, p. 1914-1924 11 p.

Research output: Contribution to journalReview article

Open Access
4 Scopus citations

Implementation of artificial intelligence (AI) for lung cancer clinical trial matching in a tertiary cancer center

Leventakos, K., Helgeson, J., Mansfield, A. S., Deering, E., Schwecke, A., Adjei, A., Molina, J., Hocum, C., Halfdanarson, T., Marks, R., Parikh, K., Pomerleau, K., Coverdill, S., Rammage, M. & Haddad, T., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, p. ii74

Research output: Contribution to journalArticle

Open Access

Lung Cancer Worldwide

Adjei, A. A., Jun 2019, In : Journal of Thoracic Oncology. 14, 6, 1 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Outstanding Issues with Umbrella and Basket Studies

Parikh, K. & Adjei, A. A., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1685-1688 4 p.

Research output: Contribution to journalEditorial

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

Tsao, M. S., Carbone, M., Galateau-Salle, F., Moreira, A. L., Nicholson, A. G., Roden, A. C., Adjei, A. A., Aubry, M. C., Fennell, D. A., Gomez, D., Harpole, D., Hesdorffer, M., Hirsch, F. R., Liu, G., Malik, S., Nowak, A., Peikert, T., Salgia, R., Szlosarek, P., Taioli, E. & 3 others, Yang, H., Tsao, A. & Mansfield, A. S., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1704-1717 14 p.

Research output: Contribution to journalArticle

1 Scopus citations

Progress in the Diagnosis and Treatment of Thoracic Malignancies Continues Unabated

Adjei, A. A., May 2019, In : Journal of Thoracic Oncology. 14, 5, 1 p.

Research output: Contribution to journalEditorial

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting

Gill, R. R., Tsao, A. S., Kindler, H. L., Richards, W. G., Armato, S. G., Francis, R. J., Gomez, D. R., Dahlberg, S., Rimner, A., Simone, C. B., de Perrot, M., Blumenthal, G., Adjei, A. A., Bueno, R., Harpole, D. H., Hesdorffer, M., Hirsch, F. R., Pass, H. I., Yorke, E., Rosenzweig, K. & 10 others, Burt, B., Fennell, D. A., Lindwasser, W., Malik, S., Peikert, T., Mansfield, A. S., Salgia, R., Yang, H., Rusch, V. W. & Nowak, A. K., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1718-1731 14 p.

Research output: Contribution to journalArticle

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

10 Scopus citations

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Gomez, D. R., Rimner, A., Simone, C. B., Cho, B. C. J., de Perrot, M., Adjei, A. A., Bueno, R., Gill, R. R., Harpole, D. H., Hesdorffer, M., Hirsch, F. R., Jackson, A. A., Pass, H. I., Rice, D. C., Rusch, V. W., Tsao, A. S., Yorke, E. & Rosenzweig, K., Jul 2019, In : Journal of Thoracic Oncology. 14, 7, p. 1172-1183 12 p.

Research output: Contribution to journalReview article

Open Access
7 Scopus citations
2018

2017—A Banner Year for Thoracic Oncology

Adjei, A., Mar 1 2018, In : Journal of Thoracic Oncology. 13, 3, p. e33-e34

Research output: Contribution to journalEditorial

A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer

Wahner Hendrickson, A. E., Costello, B., Jewell, A., Kennedy, V., Fleming, G., Corr, B., Taylor, S. E., Lea, J., Reid, J., Swisher, E., Satele, D., Allred, J., Lensing, J., Ivy, S. P., Erlichman, C., Adjei, A. A. & Kaufmann, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii357

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer

Goyal, G., Kommalapati, A., Bartley, A. C., Gunderson, T. M., Adjei, A. & Go, R. S., Aug 1 2018, In : Lung Cancer. 122, p. 214-219 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations

Le-Rademacher, J., Dahlberg, S., Lee, J. J., Adjei, A. & Mandrekar, S. J., Nov 1 2018, In : Journal of Thoracic Oncology. 13, 11, p. 1625-1637 13 p.

Research output: Contribution to journalReview article

5 Scopus citations

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Tsao, A. S., Lindwasser, O. W., Adjei, A. A., Adusumilli, P. S., Beyers, M. L., Blumenthal, G. M., Bueno, R., Burt, B. M., Carbone, M., Dahlberg, S. E., de Perrot, M., Fennell, D. A., Friedberg, J., Gill, R. R., Gomez, D. R., Harpole, D. H., Hassan, R., Hesdorffer, M., Hirsch, F. R., Hmeljak, J. & 21 others, Kindler, H. L., Korn, E. L., Liu, G., Mansfield, A. S., Nowak, A. K., Pass, H. I., Peikert, T., Rimner, A., Robinson, B. W. S., Rosenzweig, K. E., Rusch, V. W., Salgia, R., Sepesi, B., Simone, C. B., Sridhara, R., Szlosarek, P., Taioli, E., Tsao, M. S., Yang, H., Zauderer, M. G. & Malik, S. M., Nov 2018, In : Journal of Thoracic Oncology. 13, 11, p. 1655-1667 13 p.

Research output: Contribution to journalArticle

26 Scopus citations

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., Mansfield, A. S., Park, S. S., Markovic, S. N., Dronca, R. S. & Dong, H., Apr 19 2018, In : JCI Insight. 3, 8

Research output: Contribution to journalArticle

Open Access
20 Scopus citations

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Moschos, S. J., Sullivan, R. J., Hwu, W. J., Ramanathan, R. K., Adjei, A. A., Fong, P. C., Shapira-Frommer, R., Tawbi, H. A., Rubino, J., Rush, T. S., Zhang, D., Miselis, N. R., Samatar, A. A., Chun, P., Rubin, E. H., Schiller, J., Long, B. J., Dayananth, P., Carr, D., Kirschmeier, P. & 8 others, Bishop, W. R., Deng, Y., Cooper, A., Shipps, G. W., Moreno, B. H., Robert, L., Ribas, A. & Flaherty, K. T., Feb 22 2018, In : JCI Insight. 3, 4

Research output: Contribution to journalArticle

Open Access
32 Scopus citations

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Soyano, A. E., Dholaria, B., Marin-Acevedo, J. A., Diehl, N., Hodge, D., Luo, Y., Manochakian, R., Chumsri, S., Adjei, A., Knutson, K. L. & Lou, Y., Nov 23 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 129.

Research output: Contribution to journalArticle

21 Scopus citations

Representation of minorities and women in oncology clinical trials: Review of the past 14 years

Duma, N., Aguilera, J. V., Paludo, J., Haddox, C. L., Velez, M. G., Wang, Y., Leventakos, K., Hubbard, J. M., Mansfield, A., Go, R. S. & Adjei, A., Jan 1 2018, In : Journal of Oncology Practice. 14, 1, p. e1-e10

Research output: Contribution to journalReview article

23 Scopus citations

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M. M., Patel, N. M., Miller, R. C., Adjei, A. A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

6 Scopus citations

What is a “High-Impact” Journal?

Adjei, A., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

2017
39 Scopus citations

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer

Soria, J. C., Adjei, A., Bahleda, R., Besse, B., Ferte, C., Planchard, D., Zhou, J., Ware, J., Morrissey, K., Shankar, G., Lin, W., Schutzman, J. L., Dy, G. K. & Groen, H. J. M., Nov 1 2017, In : European Journal of Cancer. 86, p. 186-196 11 p.

Research output: Contribution to journalArticle

9 Scopus citations

A phase I clinical trial and independent patient-derived xenograft study of combined targeted treatment with dacomitinib and figitumumab in advanced solid tumors

Calvo, E., Soria, J. C., Ma, W. W., Wang, T., Bahleda, R., Tolcher, A. W., Gernhardt, D., O'Connell, J., Millham, R., Giri, N., Wick, M. J., Adjei, A. A. & Hidalgo, M., Mar 1 2017, In : Clinical Cancer Research. 23, 5, p. 1177-1185 9 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors

Adjei, A. A., LoRusso, P., Ribas, A., Sosman, J. A., Pavlick, A., Dy, G. K., Zhou, X., Gangolli, E., Kneissl, M., Faucette, S., Neuwirth, R. & Bózon, V., Feb 1 2017, In : Investigational New Drugs. 35, 1, p. 47-58 12 p.

Research output: Contribution to journalArticle

11 Scopus citations

Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

Xie, H. & Adjei, A., Dec 1 2017, In : Translational Lung Cancer Research. 6, p. S41-S43

Research output: Contribution to journalEditorial

1 Scopus citations

First-in-human phase I Study of the tamoxifen metabolite Z-endoxifen in women with endocrine-refractory metastatic breast cancer

Goetz, M. P., Suman, V. J., Reid, J. M., Northfelt, D. W., Mahr, M. A., Ralya, A. T., Kuffel, M., Visscher, S. A., Kipp, B. R., Liu, M. C., Hawse, J. R., Ames, M. M., Ingle Buhrow, J. N., Safgren, S. L., McGovern, R. M., Black, J., Dockter, T., Haddad, T. C., Erlichman, C., Adjei, A. & 7 others, Collins, D., Streicher, H., Chalmers, Z. R., Frampton, G., Hawse, J. R., Doroshow, J. H. & Collins, J. M., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3391-3400 10 p.

Research output: Contribution to journalArticle

29 Scopus citations

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Mayo Clinic, North Central Cancer Treatment Group, Apr 1 2017, In : Journal of Thoracic Oncology. 12, 4, p. 697-703 7 p.

Research output: Contribution to journalArticle

7 Scopus citations